Canada markets open in 5 hours 26 minutes
  • S&P/TSX

    19,321.92
    +150.26 (+0.78%)
     
  • S&P 500

    4,170.42
    +45.76 (+1.11%)
     
  • DOW

    34,035.99
    +305.10 (+0.90%)
     
  • CAD/USD

    0.7990
    +0.0013 (+0.17%)
     
  • CRUDE OIL

    63.73
    +0.27 (+0.43%)
     
  • BTC-CAD

    77,082.99
    -2,391.87 (-3.01%)
     
  • CMC Crypto 200

    1,368.94
    -12.00 (-0.87%)
     
  • GOLD FUTURES

    1,763.30
    -3.50 (-0.20%)
     
  • RUSSELL 2000

    2,257.07
    +9.35 (+0.42%)
     
  • 10-Yr Bond

    1.5300
    0.0000 (0.00%)
     
  • NASDAQ futures

    13,975.25
    -38.75 (-0.28%)
     
  • VOLATILITY

    16.62
    -0.37 (-2.18%)
     
  • FTSE

    7,014.63
    +31.13 (+0.45%)
     
  • NIKKEI 225

    29,683.37
    +40.68 (+0.14%)
     
  • CAD/EUR

    0.6663
    +0.0005 (+0.08%)
     

/R E P E A T -- Notice to the media - Government of Canada officials to hold a technical briefing on COVID-19 vaccines in Canada/

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

OTTAWA, ON, March 24, 2021 /CNW/ - Government of Canada officials will hold a technical briefing to provide an overview on the roll-out of COVID-19 vaccines.

Officials will be available to answer questions from the media following their remarks.

Date
March 25, 2021

Time
9:30 AM (EDT)

Location

The media technical briefing will be held virtually. Media will be able to ask questions via teleconference.

Toll-free (Canada/US) dial-in number:
1-866-206-0153
Local dial-in number:
613-954-9003

Passcode: 1622050#

To obtain the briefing material under embargo, please RSVP by email at hc.media.sc@canada.ca.

NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.

Twitter:@GovCanHealth
Facebook: Healthy Canadians

SOURCE Public Health Agency of Canada

Cision
Cision

View original content: http://www.newswire.ca/en/releases/archive/March2021/25/c5010.html